Abdominal surgery in patients with chronic noncirrhotic extrahepatic portal vein obstruction: A multicenter

Laure Elkrief1,2, Corentin Denecheau-Girard1, Marta Magaz3

  • 1Faculté de médecine et service d'hépato-gastroentérologie, CHRU de Tours, ERN RARE-LIVER, France.

PubMed

Insights

Abdominal surgery in patients with extrahepatic portal vein obstruction (EHPVO) carries a high risk of bleeding and complications. Ascites and specific surgical types increase unfavorable outcomes in these patients.

Area of Science:

  • Vascular Surgery
  • Gastroenterology
  • Surgical Outcomes

Background:

  • Data on surgical morbimortality in noncirrhotic chronic extrahepatic portal vein obstruction (EHPVO) is limited.
  • Extrahepatic portal vein obstruction (EHPVO) presents unique challenges for abdominal surgery.
  • Understanding surgical risks is crucial for managing patients with EHPVO.

Purpose of the Study:

  • To assess the morbimortality associated with abdominal surgery in patients with EHPVO.
  • To identify risk factors for adverse outcomes after surgery in EHPVO patients.
  • To compare surgical outcomes in EHPVO patients versus controls.

Main Methods:

  • Retrospective analysis of 76 patients (78 interventions) with EHPVO undergoing abdominal surgery.
  • Comparison of EHPVO patients with 126 matched control patients without EHPVO.
  • Evaluation of major bleeding, Dindo-Clavien grade ≥3 complications, portal hypertension-related complications, and mortality.

Main Results:

  • 37% of EHPVO patients experienced unfavorable outcomes (major bleeding, severe complications, or death).
  • Ascites and non-wall/non-cholecystectomy interventions were associated with increased unfavorable outcomes.
  • EHPVO patients had significantly higher rates of major bleeding and portal hypertension-related complications compared to controls.

Conclusions:

  • Patients with EHPVO face elevated risks of perioperative bleeding and postoperative complications.
  • Specific patient factors (ascites) and surgical types (non-wall, non-cholecystectomy) heighten these risks.
  • Risk stratification is essential for optimizing surgical management in EHPVO.
Abstract